Amina M. Bagher

Convergent Modifiers of Exposure Variability in Approved Cannabinoid Medicines: Pharmacogenomics, Drug–Drug Interactions, and Parent–Metabolite Divergence

Background/Objectives: Systemic exposure to the approved cannabinoid medicines cannabidiol, nabiximols, dronabinol, and nabilone varies markedly among patients. Genotype and comedication may act at shared clearance steps and alter parent-drug and active-metabolite exposures diffe...